Sacklers to pay up to $7bn in Purdue Pharma’s opioid settlement plan
Purdue Pharma’s new bankruptcy plan outlines the payment structure of the largest opioid settlement to date.
Business & Regulation
Biosimilars drive Sandoz growth ahead of unclear tariff effects in 2025
Idorsia’s Tryvio deal collapses, forcing company to find cash urgently
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Valneva hits 2024 sales target but plans lower cash burn in 2025
Trump’s tariffs could strain medicine supply and drive drug costs
Sanofi kicks off share buyback plan with $3bn L’Oréal stake purchase
UK life science startups have trouble “scaling up” says Lord Vallance
